Hedge Fund - Paradigm Biocapital Advisors
Tarsus Pharmaceuticals Inc. (TARS)
Holding History Records
| No. | Filing Period | Value | % of Portfolio | Number of Shares | Avg. Quarterly Share Price |
|---|---|---|---|---|---|
| 1 | 2025 - Q4 (2025-12-31) | $209,789,170 | 5.35% | 2,562,154 | $74.67 |
| 2 | 2025 - Q3 (2025-09-30) | $158,422,432 | 4.51% | 2,665,698 | $49.23 |
| 3 | 2025 - Q2 (2025-06-30) | $120,561,770 | 5.15% | 2,976,099 | $45.00 |
| 4 | 2025 - Q1 (2025-03-31) | $134,085,820 | 6.14% | 2,610,197 | $49.43 |
| 5 | 2024 - Q4 (2024-12-31) | $140,191,082 | 4.87% | 2,531,896 | $45.42 |
| 6 | 2024 - Q3 (2024-09-30) | $80,266,236 | 2.72% | 2,440,445 | $28.11 |
| 7 | 2024 - Q2 (2024-06-30) | $66,194,607 | 2.53% | 2,435,416 | $33.62 |
| 8 | 2024 - Q1 (2024-03-31) | $104,084,808 | 3.66% | 2,863,406 | $29.40 |
| 9 | 2023 - Q4 (2023-12-31) | $20,756,250 | 0.97% | 1,025,000 | $16.70 |
The displayed share prices are average quarterly stock market prices.
Hedge Fund Resource Center